Drug Approval Package

Lescol (Fluvastatin Sodium) Capsules
Company:  Novartis Pharmaceutical Corporation
Application No.:  20-261/S-018/S-022
Approval Date: 5/8/1999

• Approval Letter, Medical Review(s) & Chemistry Review(s) (PDF) (2 MB)

• Environmental Assessment, Pharmacology Review(s) & Administrative Document(s)/Correspondence (PDF) (1.8 MB)

Date created: March 30, 2001; last update: July 5, 2005

Back to Top    Drugs@FDA

Note: Documents in PDF format require the Adobe Acrobat Reader®.